WINTON GROUP Ltd - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 78 filers reported holding ENZO BIOCHEM INC in Q1 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.

Quarter-by-quarter ownership
WINTON GROUP Ltd ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2021$138,000
+15.0%
39,041
+3.1%
0.01%
+33.3%
Q2 2021$120,000
-9.1%
37,878
-1.1%
0.01%
-25.0%
Q1 2021$132,000
+34.7%
38,306
-2.0%
0.01%
+14.3%
Q4 2020$98,000
-22.8%
39,086
-34.9%
0.01%
+75.0%
Q3 2020$127,000
-42.0%
60,047
-38.6%
0.00%
-33.3%
Q2 2020$219,000
+73.8%
97,742
+95.7%
0.01%
+100.0%
Q1 2020$126,000
+5.9%
49,952
+9.9%
0.00%
+50.0%
Q4 2019$119,000
-33.5%
45,432
-8.4%
0.00%0.0%
Q3 2019$179,00049,6050.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q1 2020
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,736,719$9,414,00013.61%
HARBERT FUND ADVISORS, INC. 5,175,913$17,805,0008.40%
Evermore Global Advisors, LLC 2,605,607$8,963,0006.32%
KEMPNER CAPITAL MANAGEMENT INC. 95,476$328,0000.19%
CORRADO ADVISORS, LLC 46,816$161,0000.12%
MYDA Advisors LLC 35,000$120,0000.03%
Cutter & CO Brokerage, Inc. 29,827$103,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 258,700$890,0000.02%
Paradigm Financial Partners, LLC 18,000$62,0000.02%
Renaissance Technologies 3,340,864$11,493,0000.01%
View complete list of ENZO BIOCHEM INC shareholders